Transdermal hollow microneedle patches are an innovative drug delivery technology that enables efficient administration through the skin. CD Formulation specializes in the development of these patches, offering tailored solutions for diverse research applications.
Hollow microneedles are a group of microneedles similar in size to solid microneedles with small holes in the axis of the needle. The working principle is that the drug is pre-loaded in the hollow structure or needle cavity of the needle body. After the empty needle tip is pierced into the skin, the drug is driven into the body under the pressure of the concentration gradient of the tissue fluid, to achieve drug delivery. Hollow MNs are commonly used to deliver high molecular weight molecules such as oligonucleotides, vaccines, and proteins. Hollow MNs are ideal for transporting organisms (cells, bacteria, or viruses) because they have an external reservoir that keeps the organism active.
Microneedles are micron-sized needles that painlessly penetrate the stratum corneum to deliver drugs into the body. The main advantage of microneedles is that they combine the potential delivery power of a hypodermic needle with the user-friendly benefits of a transdermal patch. According to the application characteristics of microneedles, they can be divided into solid microneedles, coated microneedles, soluble microneedles, porous microneedles, and hollow microneedles (HMN). Compared to the other four classes of microneedles, HMN has important advantages, such as the ability to quickly deliver drugs directly to the body without the time-consuming slow penetration and release process, and higher drug utilization.
At CD Formulation, we provide customized development of hollow microneedle patches for various research needs:
Fig.1 Applications of hollow microneedle technology. (CD Formulation)
We utilize a range of materials to fabricate microneedles, ensuring strength, biocompatibility, and production scalability:
We employ advanced techniques for microneedle development, including:
Fig.2 Schematic diagram of fabrication principle of hollow microneedle patches (HMNPs) via static optical projection lithography. (Rong Li, et al. 2022)
Technology: Technology for Hollow Microneedle Patch
Journal: International Journal of Bioprinting
IF: 6.81
Published: 2022
Results: Hollow microneedle patches (HMNPs) have great promise for efficient and precise transdermal drug delivery in a painless manner. Currently, the clinical application of HMNPs is restricted by its complex manufacturing processes. Here, we use a new3D printing technology, static optical projection lithography (SOPL), for the fast fabrication of HMNPs. In this technology, a light beam is modulated into a customized pattern by a digital micromirror device (DMD) and projected to induce the spatial polymerization of monomer solutions which is controlled by the distribution of the light intensity in the monomer solutions. After an annulus picture is inputted into the DMD via the computer, the microneedles with a hollow-cone structure can be precisely printed in seconds. By designing the printing pictures, the personalized HMNPs can be quickly customized, which can afford the scale-up preparation of personalized HMNPs. The obtained hollow microneedles (HMNs) have smooth surfaces without layer-by-layer structure in the commonly 3D-printed products. After being equipped with a micro-syringe, the HMNPs can efficiently deliver insulin into the skin by injection, resulting in effective control of the blood glucose level in diabetic mice. This work demonstrates a SOPL-based 3D printing technology for fast customization of HMNPs with promising medical applications.
CD Formulation is at the forefront of transdermal hollow microneedle patch innovation, committed to advancing drug delivery solutions. Contact us to discuss your project requirements, and we will respond within three working days.
References